Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Tool Studies Spatial Patterns in Living Cells

November 1, 2011 12:19 pm | News | Comments

Scientists with the U.S. Department of Energy’s Lawrence Berkeley National Laboratory have developed a way to study the impact of spatial patterns on living cells.

TOPICS:

TNF-Kinoid Study Has Promising Results

November 1, 2011 12:15 pm | News | Comments

Neovacs announced promising results achieved in the first 24 rheumatoid arthritis patients included in the Phase 2a study conducted with TNF-Kinoid.

TOPICS:

Infinity Initiates PI3K Delta, Gamma Inhibitor Trials

November 1, 2011 12:12 pm | News | Comments

Infinity Pharmaceuticals Inc. has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma.

TOPICS:
Advertisement

FDA Invests $2 million in Partnerships

November 1, 2011 12:08 pm | News | Comments

The U.S. Food and Drug Administration announced the award of $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation.

TOPICS:

PPAR Agonist Reduces Cholesterol, Fat Deposition

November 1, 2011 12:04 pm | News | Comments

Spherix Inc. announced that SPX-106T reduced dyslipidemia in studies of apolipoprotein E-deficient mice and Syrian Golden hamsters.

TOPICS:

Domainex Awarded Grant for Cancer Drug Research

November 1, 2011 12:00 pm | News | Comments

Domainex Ltd. was awarded a $400,000 (£250,000) grant by the Technology Strategy Board to support the development of a new drug for the treatment of several common cancers.

TOPICS:

Nerve Protein Retains Long Term Memory

November 1, 2011 11:53 am | News | Comments

A study by two University of Illinois at Chicago biologists finds a link that the nerve signaling inhibitor, tomosyn, may help retain long-term memory.

TOPICS:

Flash Purification System

November 1, 2011 7:34 am | Product Releases | Comments

Biotage has introduced the Isolera Prime flash purification system. The system is upgradeable and can be expanding according to the needs of developing companies and academic institutions.

TOPICS:
Advertisement

Cell Biology Research Tool

November 1, 2011 7:27 am | Product Releases | Comments

Working at a rate of over 1000 measurements per second, the Cell Tester from World Precision Instruments Inc employs state-of-the-art optics, nanopositioning and force sensor technology to deliver sensitive, robust, and reproducible force measurements.

TOPICS:

Cobra Biologics Buys Unitech Pharma

November 1, 2011 7:17 am | News | Comments

Cobra Biologics, an international manufacturer of biopharmaceuticals, has acquired Unitech Pharma Group and its bio-production facility in Matfors, Sweden.

TOPICS:

Auxilium Loses Millions for the Quarter

November 1, 2011 7:04 am | News | Comments

Auxilium Pharmaceuticals Inc. reported a narrower third-quarter loss as its sales increased. Auxilium said it lost $4.1 million; a year ago the company took a larger loss of $12.8 million.

TOPICS:

Nuron Begins Late-Stage MS Trial

November 1, 2011 7:00 am | News | Comments

Nuron Biotech Inc. announced the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the safety and efficacy of NU100 in patients with relapsing remitting multiple sclerosis.

TOPICS:

FDA Accepts Generic Lamictal ANDA

November 1, 2011 6:53 am | News | Comments

Intellipharmaceutics International Inc. announced the U.S. Food and Drug Administration has accepted for filing its abbreviated new drug application for a generic version of Lamictal XR, an anticonvulsant drug used in the treatment of epilepsy.

TOPICS:

Elagolix Advancement Buoys Neurocrine Biosciences

November 1, 2011 6:47 am | News | Comments

Neurocrine Biosciences Inc. said that third-quarter jumped sharply as revenue nearly tripled as the company recognized $30 million in revenue for moving a new drug closer to regulatory approval.

TOPICS:

Consumer Advocates Push J & J on Shampoo Ingredients

November 1, 2011 6:39 am | News | Comments

Two chemicals considered harmful to babies remain in Johnson & Johnson's baby shampoo sold in the U.S. and some other countries, even though the company already makes versions without them.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading